Hinge Health, Inc. is a pioneering digital health company transforming the landscape of musculoskeletal (MSK) care through its innovative blend of technology, clinical expertise, and personalized treatment programs. Founded in 2015 by Daniel Perez and Gabriel Mecklenburg, the company was established to address the growing burden of MSK disorders, which represent one of the most prevalent and costly healthcare challenges globally. Headquartered in San Francisco, California, Hinge Health has grown from a start-up offering digital exercise therapy into a full-scale healthcare platform that serves some of the largest employers and health plans in the United States.
The company’s mission centers around empowering people to overcome chronic pain, avoid unnecessary surgeries, and regain their quality of life through effective, non-invasive treatment. What began as a digital physical therapy solution has evolved into a comprehensive MSK care ecosystem powered by AI, computer vision, motion sensors, behavioral health coaching, and direct clinical support. Hinge Health combines its virtual platform with real-time data and clinical oversight, offering members a unique end-to-end solution for managing pain and improving mobility. This model is a stark contrast to traditional MSK care, which is often fragmented, reactive, and expensive.
At the core of Hinge Health’s platform is its digital exercise therapy program, which guides members through personalized routines using computer vision and motion tracking to ensure proper form and maximize therapeutic benefit. Members are supported by a multidisciplinary care team, including physical therapists, health coaches, and physicians, all of whom coordinate remotely to deliver a seamless user experience. The program has been clinically validated through peer-reviewed studies and has demonstrated significant reductions in pain, surgical intent, and opioid usage, reinforcing the company’s position as a trusted solution for MSK health.
Hinge Health’s growth has been nothing short of remarkable. From signing its first employer client in 2017, the company has expanded to serve more than 2,250 enterprise customers and over 500,000 members. Notable clients include Fortune 500 companies, large insurers, and public institutions, many of which have adopted Hinge Health to reduce healthcare costs and improve workforce wellness. The platform boasts an impressive 98% member retention rate and has been shown to deliver average savings of more than $2,000 per member annually, making it a compelling value proposition for cost-conscious organizations.
As the demand for digital health solutions surged during the COVID-19 pandemic, Hinge Health scaled rapidly, raising multiple rounds of funding from top-tier investors including Coatue, Tiger Global, BOND, and Insight Partners. By 2021, the company had reached unicorn status with a valuation of over $6 billion in the private market. In early 2025, Hinge Health went public on the New York Stock Exchange under the ticker symbol HNGE, further solidifying its position as a leader in the digital health space. The IPO drew strong interest from institutional investors and analysts alike, thanks to the company’s strong unit economics, gross margins exceeding 80%, and early signs of profitability.
Hinge Health continues to innovate at the intersection of AI and healthcare. The company’s recent launch of HingeSelect, a high-performance provider network that integrates in-person care with its digital platform, represents a strategic expansion of its service model. HingeSelect enables members to access pre-vetted local providers—such as physical therapists and orthopedic specialists—at rates up to 50% lower than PPO benchmarks, while ensuring care consistency and reducing administrative burden. This hybrid approach positions Hinge Health to capture an even larger share of the $600+ billion MSK market by bridging the gap between virtual and in-person care.
The company’s long-term vision is anchored in the belief that much of healthcare delivery will be automated through intelligent software and connected devices, allowing providers to focus their expertise where it’s most needed. By combining high-tech tools with high-touch clinical support, Hinge Health is not only delivering better outcomes for patients but also helping to reshape the future of healthcare delivery. With its innovative technology, scalable business model, and unwavering focus on clinical excellence, Hinge Health stands as one of the most promising growth companies in the digital health sector.
Introducing HingeSelect: A High-Performance Network Unifying Digital and In-Person MSK Care
In July 2025, Hinge Health announced the launch of HingeSelect, a first-of-its-kind high-performance provider network that seamlessly integrates in-person care with Hinge’s digital platform. This move marks a major evolution in the company’s strategy—one that further differentiates Hinge from traditional digital health providers.
HingeSelect gives members access to a curated network of high-quality in-person MSK providers, including physical therapists, orthopedic physicians, imaging centers, and specialists. By leveraging Hinge Health’s proprietary AI triage and clinical team, members are guided through a unified care journey—ensuring they receive the most appropriate, evidence-based treatment whether digitally or in-person. In cases requiring services like imaging, injections, or hands-on physical therapy, users are seamlessly referred to pre-vetted providers, often at costs up to 50% lower than standard PPO rates.
This hybrid model provides a powerful one-two punch. On the front end, Hinge’s AI-powered app delivers guided exercise therapy and digital coaching that reduces pain and improves function. On the back end, when digital interventions aren’t sufficient, patients are directed to local providers through the HingeSelect network. Appointments can be booked directly within the app, and care records are automatically shared back with the Hinge team to ensure continuity.
CHECK THIS OUT: Exact Sciences (EXAS) Just Made Cancer Detection 100x Easier! and Soleno Therapeutics (SLNO): The Biotech Company That Could Make You Rich.
Reinventing Care Delivery with a Scalable AI-Driven Platform
At its core, Hinge Health is a software company using artificial intelligence to automate and scale clinical care. The company has stated that its platform is able to reduce clinician involvement by as much as 95% through automation and computer vision. This allows the company to scale rapidly while preserving high-quality care delivery. By embedding sensors and motion tracking within its digital program, Hinge can track a user’s exercise accuracy, customize therapy plans, and offer real-time feedback—all without a clinician in the room.
In Q1 2025, Hinge Health delivered exceptional results: revenue surged to $123.8 million, representing 50% growth year-over-year. The company also posted a gross margin of 81% and achieved $17.1 million in net income, signaling rare profitability in the digital health sector. These figures underscore the power of Hinge’s model: high-margin, tech-enabled care that scales efficiently.
Addressing a Massive, Underpenetrated Market
Musculoskeletal conditions are among the costliest health issues in the United States, with the market opportunity for MSK care estimated to exceed $661 billion annually. Physical therapy alone is a $70 billion segment, and Hinge’s addressable serviceable market is pegged at $18–27 billion by leading analysts. As the population ages and sedentary lifestyles increase, the demand for effective MSK treatment will only grow.
Hinge is well-positioned to dominate this space by offering a vertically integrated solution that encompasses triage, diagnostics, therapy, and follow-up. With HingeSelect now in place, the company can tackle more complex care pathways that were previously out of scope for purely digital platforms. This expanded scope creates massive revenue potential while strengthening Hinge’s defensible moat.
Analyst Confidence and Institutional Support Reinforce the Bull Case
Investor sentiment toward Hinge Health has been overwhelmingly positive. The company’s IPO in early 2025 was met with strong demand, pricing at $32 and surging more than 20% on day one. Analysts from Morgan Stanley, BofA, Needham, William Blair, RBC, Truist, and Stifel all initiated coverage with “Buy” or “Overweight” ratings. Price targets range between $42 and $48, and with shares currently trading near $46, the stock still offers meaningful upside potential.
The company’s technology, clinical outcomes, and cost-savings have made it a favorite among institutional investors and benefits consultants. Its ability to generate an average savings of $2,387 per member annually gives employers a strong incentive to adopt and retain the program. Moreover, its enterprise client base grew 36% YoY in 2024, reinforcing Hinge’s strong B2B growth engine.
The Financial and Strategic Edge of HingeSelect
HingeSelect is more than just a provider directory—it’s a strategic leap forward. By consolidating digital and in-person care into one unified ecosystem, Hinge is addressing critical inefficiencies in MSK treatment. Wait times for orthopedic appointments can exceed 20 days, and inappropriate or inconsistent treatment paths remain common. HingeSelect shortens wait times, enforces clinical standards, and slashes costs with transparent, bundled pricing.
The economic model is a win-win for everyone involved. Employers and health plans benefit from reduced medical costs and better outcomes. Patients enjoy a seamless experience with faster access to appropriate care. And Hinge Health gains a deeper level of control over the end-to-end care journey, which improves data fidelity, outcomes tracking, and future AI model training.
As Daniel Perez, Co-founder and CEO of Hinge Health, stated: “We are moving towards a future where healthcare delivery itself will be automated via software and connected hardware—but many aspects of care still require in-person providers. HingeSelect creates a unified care experience that guarantees consistent, evidence-based support every step of the way.”
Poised for Long-Term Growth Amid Industry Tailwinds
With its hybrid care model, enterprise traction, AI leadership, and profitability already in hand, Hinge Health is one of the few digital health companies that truly blends scalability with sustainability. As the U.S. healthcare system continues to prioritize value-based care and employers seek better ways to manage chronic conditions, Hinge is in the perfect position to benefit from these macro trends.
The launch of HingeSelect further accelerates the company’s path toward becoming the category-defining platform for musculoskeletal care. This added layer of care not only unlocks new revenue streams but also deepens customer stickiness and competitive differentiation.
Hinge Health’s journey is far from over. With an enormous addressable market, best-in-class technology, strong financials, and a visionary leadership team, the company is poised to be one of the standout success stories in the next wave of healthcare innovation.
READ ALSO: Johnson & Johnson (JNJ) can be the Next Trillion-Dollar Stock and Boston Scientific (BSX) Just Signed a $45M Deal—Here’s What It Means for Investors.
